Haibo Ni

Haibo Ni

Auto-generated profile, based on publicly available information

Haibo Ni

Medical School, Nanjing University

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2021 in Science Advances
Verified
Journal Article
Open access
SMStefano Morotti
Stefano Morotti
CLCaroline Liu
Caroline Liu
BHBence Hegyi
Bence Hegyi
HNHaibo Ni
Haibo Ni
AIAlex Fogli Iseppe
Alex Fogli Iseppe
EGEleonora Grandi
Eleonora Grandi
Found in translation: We present quantitative tools that map cardiac myocyte physiology and pharmacology across species.

13 June 2017 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
DWDominic G Whittaker
Dominic G Whittaker
HNHaibo Ni
Haibo Ni
AHAziza El Harchi
Aziza El Harchi
JHJules C Hancox
Jules C Hancox
HZHenggui Zhang
Henggui Zhang
Gain-of-function mutations in KCNJ2-encoded Kir2.1 channels underlie variant 3 (SQT3) of the short QT syndrome, which is associated with atrial fibrillation (AF). Using biophysically-detailed human atria computer models, this study investigated the mechanistic link between SQT3 mutations and atrial arrhythmogenesis, and potential ion channel targets for treatment of SQT3. A contemporary model of the human atrial action potential (AP) was modified to recapitulate functional changes in IK1 due to heterozygous and homozygous forms of the D172N and E299V Kir2.1 mutations. Wild-type (WT) and mutant formulations were incorporated into multi-scale homogeneous and heterogeneous tissue models. Effects of mutations on AP duration (APD), conduction velocity (CV), effective refractory period (ERP), tissue excitation threshold and their rate-dependence, as well as the wavelength of re-entry (WL) were quantified. The D172N and E299V Kir2.1 mutations produced distinct effects on IK1 and APD shortening. Both mutations decreased WL for re-entry through a reduction in ERP and CV. Stability of re-entrant excitation waves in 2D and 3D tissue models was mediated by changes to tissue excitability and dispersion of APD in mutation conditions. Combined block of IK1 and IKr was effective in terminating re-entry associated with heterozygous D172N conditions, whereas IKr block alone may be a safer alternative for the E299V mutation. Combined inhibition of IKr and IKur produced a synergistic anti-arrhythmic effect in both forms of SQT3. In conclusion, this study provides mechanistic insights into atrial proarrhythmia with SQT3 Kir2.1 mutations and highlights possible pharmacological strategies for management of SQT3-linked AF. Atrial fibrillation (AF) is the most common cardiac arrhythmia, and is characterised by complex and irregular electrical activation of the upper chambers of the heart. One rare, genetic condition associated with increased risk of AF is the short QT syndrome (SQTS), which is caused by mutations in genes involved in normal electrical function of the heart. Underlying mechanisms by which SQTS-related gene mutations facilitate development of arrhythmias in the human atria are not well understood. In this study, sophisticated computer models representing ‘virtual’ human atria, incorporating detailed electrophysiological data at the ‘ion channel’ protein level into both idealised and realistic multi-scale tissue geometries, were used to dissect mechanisms by which two mutations in the KCNJ2 gene responsible for SQTS variant 3 (SQT3) promote initiation and sustenance of arrhythmias. It was found that the D172N and E299V mutations to KCNJ2 accelerated the repolarisation process at the cellular level through distinct mechanisms. This, along with the way the mutations affected heterogeneity in electrical behaviour at the organ level, mediated stability of arrhythmias and response to simulated ion channel block. This study improves understanding of mechanisms underlying increased AF risk associated with D172N and E299V KCNJ2 mutations, and outlines potential therapeutic strategies.

25 May 2020 in Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences
Verified
Journal Article
Closed access
RCRichard H. Clayton
Richard H. Clayton
YAYasser Aboelkassem
Yasser Aboelkassem
CCChris D. Cantwell
Chris D. Cantwell
CCCesare Corrado
Cesare Corrado
TDTammo Delhaas
Tammo Delhaas
RSRodrigo Weber Dos Santos
Rodrigo Weber Dos Santos
Models of electrical activation and recovery in cardiac cells and tissue have become valuable research tools, and are beginning to be used in safety-critical applications including guidance for clinical procedures and for drug safety assessment. As a consequence, there is an urgent need for a more detailed and quantitative understanding of the ways that uncertainty and variability influence model predictions. In this paper, we review the sources of uncertainty in these models at different spatial scales, discuss how uncertainties are communicated across scales, and begin to assess their relative importance. We conclude by highlighting important challenges that continue to face the cardiac modelling community, identifying open questions, and making recommendations for future studies.This article is part of the theme issue ‘Uncertainty quantification in cardiac and cardiovascular modelling and simulation’.

16 June 2017 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
MCMichael A. Colman
Michael A. Colman
HNHaibo Ni
Haibo Ni
BLBo Liang
Bo Liang
NSNicole Schmitt
Nicole Schmitt
HZHenggui Zhang
Henggui Zhang
A recent experimental study investigating patients with lone atrial fibrillation identified six novel mutations in the KCNA5 gene. The mutants exhibited both gain- and loss-of-function of the atrial specific ultra-rapid delayed rectifier K+ current, IKur. The aim of this study is to elucidate and quantify the functional impact of these KCNA5 mutations on atrial electrical activity. A multi-scale model of the human atria was updated to incorporate detailed experimental data on IKur from both wild-type and mutants. The effects of the mutations on human atrial action potential and rate dependence were investigated at the cellular level. In tissue, we assessed the effects of the mutations on the vulnerability to unidirectional conduction patterns and dynamics of re-entrant excitation waves. Gain-of-function mutations shortened the action potential duration in single cells, and stabilised and accelerated re-entrant excitation in tissue. Loss-of-function mutations had heterogeneous effects on action potential duration and promoted early-after-depolarisations following beta-adrenergic stimulation. In the tissue model, loss-of-function mutations facilitated breakdown of excitation waves at more physiological excitation rates than the wild-type, and the generation of early-after-depolarisations promoted unidirectional patterns of excitation. Gain- and loss-of-function IKur mutations produced multiple mechanisms of atrial arrhythmogenesis, with significant differences between the two groups of mutations. This study provides new insights into understanding the mechanisms by which mutant IKur contributes to atrial arrhythmias. In addition, as IKur is an atrial-specific channel and a number of IKur-selective blockers have been developed as anti-AF agents, this study also helps to understand some contradictory results on both pro- and anti-arrhythmic effects of blocking IKur. In a recent study, six mutations resulting in either gain-of-function or loss-of-function in the ultra-rapid delayed rectifier potassium current IKur, were identified to be associated with atrial fibrillation (AF). However, the causative link between the mutant IKur (either gain- or loss-of-function) and AF genesis, especially the difference and similarity between the two mutant groups, has not been elucidated. In our study, we used multiscale computational models to investigate the mechanism of arrhythmogenesis mediated by the two groups of mutations. The results suggest that the gain-of-function mutations shortened atrial action potential duration, stabilised and accelerated re-entrant excitation waves in tissue; the loss-of-function mutation promoted early-after-depolarisations following beta-adrenergic stimulation and thus wave breaks in tissue. We show these two groups of mutants carrying IKur produced multiple mechanisms of atrial arrhythmogenesis, with significant differences between the two groups. Our study provides new insights into understanding the mechanisms by which mutant IKur contributes to atrial arrhythmias. In addition, as IKur is an atrial-specific channel and a number of IKur-selective blockers have been developed as anti-AF agents, this study also helps to understand some contradictory results on both pro- and anti-arrhythmic effects of blocking IKur.

15 July 2020 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
HNHaibo Ni
Haibo Ni
AIAlex Fogli Iseppe
Alex Fogli Iseppe
WGWayne R. Giles
Wayne R. Giles
SNSanjiv M. Narayan
Sanjiv M. Narayan
HZHenggui Zhang
Henggui Zhang
EGEleonora Grandi
Eleonora Grandi

1 September 2015
Verified
Conference Paper
Closed access
DWDominic G Whittaker
Dominic G Whittaker
MCMichael A Colman
Michael A Colman
HNHaibo Ni
Haibo Ni
JHJules C Hancox
Jules C Hancox
HZHenggui Zhang
Henggui Zhang
Short QT syndrome (SQTS) patients are prone to atrial arrhythmias. However, the link between SQTS gene mutations and atrial pro-arrhythmia is not well understood. This study investigated the functional impact of two SQTS-related gain-of-function potassium channel mutations on the electro-mechanical activities of human atrial cells. A contemporary human atrial action potential (AP) model was coupled to the Rice et al. mechanics model. Markov formulations of the rapid and slow delayed rectifier currents, iKr and iKs, the a subunits of which are encoded by the hERG and KCNQJ genes, respectively, were implemented in wild type (WT), N588K-hERG (SQTJ), and V307L-KCNQJ (SQT2) conditions. The Markov models were validated against experimental data through simulated voltage and AP clamp experiments. The N588K-hERG and V307L-KCNQJ mutations were found to accelerate atrial repolarisation by increasing outward potassium currents during phase 3 of the AP, which reduced action potential duration at 90% repolarisation (APD90). Secondary effects of the mutations resulted in impaired contractile force, an effect which was lessened when stretch-activated channels (SACs) were incorporated.